PL2117568T3 - Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie - Google Patents

Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie

Info

Publication number
PL2117568T3
PL2117568T3 PL08712679T PL08712679T PL2117568T3 PL 2117568 T3 PL2117568 T3 PL 2117568T3 PL 08712679 T PL08712679 T PL 08712679T PL 08712679 T PL08712679 T PL 08712679T PL 2117568 T3 PL2117568 T3 PL 2117568T3
Authority
PL
Poland
Prior art keywords
preparation
application
purified bacteriophage
bacteriophage
purified
Prior art date
Application number
PL08712679T
Other languages
English (en)
Inventor
Tomasz Lipiński
Andrzej Gamian
Ewa Zuziak
Agnieszka Korzeniowska-Kowal
Andrzej Górski
Original Assignee
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Publication of PL2117568T3 publication Critical patent/PL2117568T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL08712679T 2007-02-09 2008-02-08 Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie PL2117568T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL381730A PL212099B1 (pl) 2007-02-09 2007-02-09 Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie

Publications (1)

Publication Number Publication Date
PL2117568T3 true PL2117568T3 (pl) 2017-01-31

Family

ID=39495222

Family Applications (2)

Application Number Title Priority Date Filing Date
PL381730A PL212099B1 (pl) 2007-02-09 2007-02-09 Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie
PL08712679T PL2117568T3 (pl) 2007-02-09 2008-02-08 Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL381730A PL212099B1 (pl) 2007-02-09 2007-02-09 Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie

Country Status (5)

Country Link
US (1) US9255251B2 (pl)
EP (1) EP2117568B1 (pl)
DK (1) DK2117568T3 (pl)
PL (2) PL212099B1 (pl)
WO (1) WO2008097115A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022134B1 (en) * 2006-04-27 2017-01-18 Tyco Electronics Services GmbH Antennas, devices and systems based on metamaterial structures
KR101236226B1 (ko) * 2006-08-25 2013-02-21 레이스팬 코포레이션 메타물질 구조물에 기초된 안테나
US7855696B2 (en) * 2007-03-16 2010-12-21 Rayspan Corporation Metamaterial antenna arrays with radiation pattern shaping and beam switching
TWI376838B (en) * 2007-10-11 2012-11-11 Tyco Electronics Services Gmbh Single-layer metallization and via-less metamaterial structures
PL213166B1 (pl) * 2008-10-29 2013-01-31 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów
PL212796B1 (pl) * 2008-11-07 2012-11-30 Inst Immunologii I Terapii Doswiadczalnej Pan Diagnostyczny preparat immunologiczny oraz jego zastosowanie
GB2466177A (en) * 2008-12-03 2010-06-16 Arab Science & Technology Found Bacteriophage selection and breeding
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CA2901690A1 (en) 2014-08-27 2016-02-27 The Governors Of The University Of Alberta Bacteriophage-based biosensor for microbial detection
RU2613423C1 (ru) * 2015-12-28 2017-03-16 Евгений Олегович Рубальский Способ получения бактериофага
CN107893058A (zh) * 2017-11-20 2018-04-10 大连雅立峰生物制药有限公司 一种去除疫苗制品中内毒素的方法
CN109593728A (zh) * 2018-11-17 2019-04-09 菲吉乐科(南京)生物科技有限公司 一种噬菌体絮凝剂及其在发酵后处理工艺中的应用
CA3153055A1 (en) * 2019-10-01 2021-04-08 Adaptive Phage Therapeutics, Inc. Method for purification of bacteriophage particles
CN112175915B (zh) * 2020-10-12 2022-11-18 上海市公共卫生临床中心 一种噬菌体制剂中内毒素的去除方法及应用
CN116987577B (zh) * 2023-09-27 2024-11-08 深圳国家感染性疾病临床医学研究中心 一种低内毒素噬菌体制剂的制备方法及其制备系统
CN118620846B (zh) * 2024-03-25 2024-12-03 武汉格瑞农生物科技有限公司 一株针对耐药豚鼠气单胞菌的噬菌体及其在水产养殖中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589591A (en) * 1986-07-03 1996-12-31 Advanced Magnetics, Inc. Endotoxin-free polysaccharides
GB2327945A (en) 1997-07-31 1999-02-10 Medeva Europ Ltd Removal of endotoxin from vaccines
CA2304123A1 (en) 2000-04-19 2001-10-19 Mount Sinai Hospital Antibacterial therapy for multi-drug resistant bacteria
PL354822A1 (pl) * 2002-06-30 2004-01-12 Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu Sposób otrzymywania oczyszczonych preparatów bakteriofagowych oraz nowe zastosowania polisacharydu lub jego estryfikowanej pochodnej
US20090297561A1 (en) * 2003-09-03 2009-12-03 Intralytix Method for vaccination of poultry by bacteriophage lysate bacterin

Also Published As

Publication number Publication date
PL381730A1 (pl) 2008-08-18
EP2117568B1 (en) 2016-08-03
US9255251B2 (en) 2016-02-09
DK2117568T3 (en) 2016-11-21
EP2117568A1 (en) 2009-11-18
PL212099B1 (pl) 2012-08-31
US20110008873A1 (en) 2011-01-13
WO2008097115A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
PL2117568T3 (pl) Oczyszczony bakteriofag, jego otrzymywanie i zastosowanie
ZA201000419B (en) Catalyst composition, its preparation and use
IL214614A0 (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
IL241632A0 (en) History of benzodiazepines, preparations containing them and their uses
IL210722A0 (en) Benzazepine derivatives, compositions comprising the same and uses thereof
SI2217578T1 (sl) (1,2,4)triazolo(1,5-a)piridinske in (1,2,4)triazolo(1,5-c)pirimidinske spojine in njihova uporaba
IL216254A (en) Compounds, pharmaceutical compositions and their uses
MY143179A (en) Novel bacteriophage and antibacterial composition comprising the same
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
EP2307344A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, PREPARATION AND USE THEREOF
GB2451750B (en) Modified bacteriophage
EP2199402A4 (en) CYCLOASTRAGENOL MONOGLYCOSIDE, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF
EP2283005A4 (en) CISATRACURIUM DERIVATIVES, PREPARATION AND USES THEREOF
GB0706077D0 (en) Methods, Compositions and uses thereof
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
PL2266619T3 (pl) Kompozycja farmaceutyczna na bazie środków chroniących wątrobę i środków prebiotycznych, ich wytwarzanie i zastosowanie
IL193384A0 (en) Substituted prolinamides, their preparation and their use as pharmaceuticals
EP2192122A4 (en) DITHIOLOPYRROLON COMPOUNDS, THEIR PREPARATION AND THEIR USE
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
PL2376479T3 (pl) Podstawione furanokarboksyamidy i ich zastosowanie
IL213996A0 (en) Sulfamoyl-phenyl-ureido-benzamidine derivatives, compositions comprising the same and uses thereof
IL205987A0 (en) Bank1 splice variant, its preparation and use
AP2012006129A0 (en) Benzamide derivatives, preparation and use thereof.
PL383212A1 (pl) Nowa DD-karboksypeptydaza, jej otrzymywanie i zastosowania
ZA200808225B (en) Substituted prolinamides, production thereof and their use as drugs